Maruho Europe Limited clinical trials
A country office of Maruho Co., Ltd.
The registry lists 6 studies whose lead sponsor is Maruho Europe Limited. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 3, 2019.
Registry sponsor names on this page
- Maruho Europe Limited6 studies
Something wrong with this grouping? Tell us on the Maruho Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Maruho Co., Ltd. studies →
- Drug-Drug Interaction Study: ASP2151 and CiclosporinCompletedNCT02280421Phase 1
Sponsor listed in the registry: Maruho Europe Limited
- Drug-Drug Interaction Study: ASP2151 and MontelukastCompletedNCT02321748Phase 1
Sponsor listed in the registry: Maruho Europe Limited
- Drug-Drug Interaction Study: ASP2151 and RitonavirCompletedNCT02223351Phase 1
Sponsor listed in the registry: Maruho Europe Limited
- Drug-Drug Interaction Study: ASP2151 and BupropionCompletedNCT02369172Phase 1
Sponsor listed in the registry: Maruho Europe Limited
- Drug-Drug Interaction Study: ASP2151 and MidazolamCompletedNCT02403635Phase 1
Sponsor listed in the registry: Maruho Europe Limited
- Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis PatientsCompletedNCT01989429Phase 3
Sponsor listed in the registry: Maruho Europe Limited